Breaking News Instant updates and real-time market news.

BIIB

Biogen

$281.96

58.39 (26.12%)

08:46
10/23/19
10/23
08:46
10/23/19
08:46

Biogen upgraded to Outperform at SVB Leerink

As previously reported, SVB Leerink analyst Geoffrey Porges upgraded Biogen to Outperform from Market Perform with a price target of $350, up from $256. The analyst is ambivalent about the prospects for the company's most important product, which is once again aducanumab, but even with relatively conservative assumptions, and a 50% probability of approval, his fair value estimate for the stock easily reaches $350.

BIIB Biogen
$281.96

58.39 (26.12%)

10/23/19
COWN
10/23/19
NO CHANGE
Target $325
COWN
Outperform
Biogen price target raised to $325 from $275 at Cowen
Cowen analyst Phil Nadeau raised his price target on Biogen to $325 from $275 following its better than expected Q3 results. The company also announced they plan to submit a BLA for aducanumab based on a new analyses of the Phase lll's and interaction with the FDA. Though its approval prospects remain unclear, he thinks the company's decision is rational. Nadeau reiterated his Outperform rating on Biogen shares.
10/23/19
FBCO
10/23/19
NO CHANGE
Target $260
FBCO
Underperform
Biogen price target raised to $260 from $203 at Credit Suisse
Credit Suisse analyst Evan Seigerman price target raised to $260 from $203 saying that while unanswered questions remain for aducanumab, given a possibility of FDA approval he is adding in risk-adjusted sales. The analyst reiterates an Underperform rating until he has a clear path forward and more clarity on the data. Despite explanations from management, Seigerman remains "confused and surprised" that Biogen now plans to file a BLA for aducanumab in early 2020 based on the same clinical data that resulted in the futility analysis and subsequent discontinuation in March of this year.
10/23/19
ADAM
10/23/19
NO CHANGE
Target $305
ADAM
Hold
Biogen price target raised to $305 from $285 at Canaccord
Canaccord analyst Suman Kulkarni raised his price target on Biogen to $305 from $285 based on a 20% potential approval for its Alzheimer's drug, aducanumab. The analyst has a best-case scenario of a full approval with a price target that could be as high as $457. Kulkarni maintained his Hold rating on Biogen shares.
10/23/19
BMOC
10/23/19
NO CHANGE
Target $297
BMOC
Market Perform
Biogen price target raised to $297 from $250 at BMO Capital
BMO Capital analyst George Farmer raised his price target on Biogen to $297 after its new results from Phase 3 trials supported the potential of aducanumab in the treatment of early Alzheimer's disease. The analyst notes that his new price target reflects the update of his model to include a-mab sales and royalty estimates, but he keeps his Market Perform rating on the stock pending presentation of a-mab Phase 3 results atCTAD in December.

TODAY'S FREE FLY STORIES

ANCN

Anchiano Therapeutics

$1.93

-0.32 (-14.22%)

08:54
11/18/19
11/18
08:54
11/18/19
08:54
Downgrade
Anchiano Therapeutics rating change  »

Anchiano Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$125.95

-0.37 (-0.29%)

, WLK

Westlake Chemical

$71.25

-1.25 (-1.72%)

08:53
11/18/19
11/18
08:53
11/18/19
08:53
Conference/Events
Jefferies to hold a bus tour »

Texas Chemical Bus Tour…

CE

Celanese

$125.95

-0.37 (-0.29%)

WLK

Westlake Chemical

$71.25

-1.25 (-1.72%)

LYB

LyondellBasell

$95.94

0.07 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 20

    Nov

  • 04

    Dec

AON

Aon plc

$198.67

0.01 (0.01%)

08:52
11/18/19
11/18
08:52
11/18/19
08:52
Downgrade
Aon plc rating change  »

Aon plc downgraded two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTY

Coty

$11.90

-0.05 (-0.42%)

08:52
11/18/19
11/18
08:52
11/18/19
08:52
Hot Stocks
Coty enters partnership with Kylie Jenner, acquires 51% of partnership for $600M »

Coty and Kylie Jenner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ARTL

Artelo Biosciences

$2.19

0.04 (1.86%)

08:51
11/18/19
11/18
08:51
11/18/19
08:51
Hot Stocks
Artelo announces publication of fatty acid binding protein 5 inhibitor data »

Artelo Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMC

Marsh & McLennan

$105.50

0.16 (0.15%)

08:51
11/18/19
11/18
08:51
11/18/19
08:51
Upgrade
Marsh & McLennan rating change  »

Marsh & McLennan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QDEL

Quidel

$64.10

2.33 (3.77%)

08:50
11/18/19
11/18
08:50
11/18/19
08:50
Recommendations
Quidel analyst commentary  »

Quidel price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$40.01

-0.395 (-0.98%)

08:50
11/18/19
11/18
08:50
11/18/19
08:50
Hot Stocks
Toll Brothers, JD Capital USA launch joint venture to develop rental community »

Toll Brothers, through…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DERM

Dermira

$7.63

0.085 (1.13%)

, GWPH

GW Pharmaceuticals

$108.35

2.32 (2.19%)

08:49
11/18/19
11/18
08:49
11/18/19
08:49
Conference/Events
Guggenheim to hold a conference »

Healthcare Talks -…

DERM

Dermira

$7.63

0.085 (1.13%)

GWPH

GW Pharmaceuticals

$108.35

2.32 (2.19%)

REGN

Regeneron

$344.56

6.21 (1.84%)

ARNA

Arena Pharmaceuticals

$45.84

0.38 (0.84%)

ZGNX

Zogenix

$45.11

-0.23 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

LOV

Spark Networks

$5.59

(0.00%)

, CRTO

Criteo

$16.57

-0.38 (-2.24%)

08:47
11/18/19
11/18
08:47
11/18/19
08:47
Hot Stocks
Spark Networks CEO Jeronimo Folgueira to step down, Eric Eichmann to succeed »

Spark Networks (LOV)…

LOV

Spark Networks

$5.59

(0.00%)

CRTO

Criteo

$16.57

-0.38 (-2.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

FIZZ

National Beverage

$43.41

0.54 (1.26%)

, KO

Coca-Cola

$52.67

0.03 (0.06%)

08:47
11/18/19
11/18
08:47
11/18/19
08:47
Recommendations
National Beverage, Coca-Cola analyst commentary  »

Coca-Cola's…

FIZZ

National Beverage

$43.41

0.54 (1.26%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

08:46
11/18/19
11/18
08:46
11/18/19
08:46
Conference/Events
The Medicines Co. to host conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$3.00

-1.6 (-34.78%)

08:45
11/18/19
11/18
08:45
11/18/19
08:45
Recommendations
Limbach Holding analyst commentary  »

Limbach Holding price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$16.79

0.23 (1.39%)

08:45
11/18/19
11/18
08:45
11/18/19
08:45
Hot Stocks
Embraer says CIAF Leasing signs order for three E190 jets »

Embraer and Cairo-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADT

ADT Inc.

$8.39

0.13 (1.57%)

, APHA

Aphria

$4.25

-0.175 (-3.96%)

08:45
11/18/19
11/18
08:45
11/18/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ADT

ADT Inc.

$8.39

0.13 (1.57%)

APHA

Aphria

$4.25

-0.175 (-3.96%)

RVLV

Revolve Group

$15.46

-0.17 (-1.09%)

HEAR

Turtle Beach

$8.68

-0.18 (-2.03%)

CGC

Canopy Growth

$15.33

-0.515 (-3.25%)

NAK

Northern Dynasty

$0.56

0.0053 (0.96%)

FAZ

Direxion Financial Bear 3x

$30.70

-0.25 (-0.81%)

CBL

CBL & Associates

$1.46

0.01 (0.69%)

CRWD

Crowdstrike

$59.79

6.96 (13.17%)

BLDP

Ballard Power

$6.91

0.33 (5.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

  • 12

    Dec

  • 19

    Dec

08:45
11/18/19
11/18
08:45
11/18/19
08:45
General news
Treasury Action: reports that China may be having second thoughts »

Treasury Action: reports…

TRHC

Tabula Rasa HealthCare

$42.09

1 (2.43%)

08:44
11/18/19
11/18
08:44
11/18/19
08:44
Hot Stocks
Tabula Rasa HealthCare announces pharmacy services agreement with WelbeHealth »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

OKTA

Okta

08:43
11/18/19
11/18
08:43
11/18/19
08:43
Downgrade
Okta rating change  »

Okta downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

HPQ

HP Inc.

$20.17

0.05 (0.25%)

, XRX

Xerox

$38.95

0.295 (0.76%)

08:43
11/18/19
11/18
08:43
11/18/19
08:43
Recommendations
HP Inc., Xerox analyst commentary  »

HP letter to Xerox…

HPQ

HP Inc.

$20.17

0.05 (0.25%)

XRX

Xerox

$38.95

0.295 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 09

    Dec

TBPMF

Tetra Bio Pharma

$0.00

(0.00%)

08:42
11/18/19
11/18
08:42
11/18/19
08:42
Hot Stocks
Tetra Bio Pharma secures financing for Hemp Energy Drink business »

Tetra Bio-Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SG

Sirius International Insurance Group

$7.80

0.1 (1.30%)

08:42
11/18/19
11/18
08:42
11/18/19
08:42
Hot Stocks
Sirius International Insurance Group confirms Frucher as Non-Executive Chairman »

Sirius International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNA

Synaptics

$60.38

-0.04 (-0.07%)

08:41
11/18/19
11/18
08:41
11/18/19
08:41
Hot Stocks
Swisscom launches IPTV media streaming box powered by Synaptics »

Synaptics Incorporated,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPST

Capstone Turbine

$2.60

0.005 (0.19%)

08:40
11/18/19
11/18
08:40
11/18/19
08:40
Hot Stocks
Capstone Turbine announces 1 MW project in Colombia with Ecopetrol »

Capstone Turbine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$16.79

0.23 (1.39%)

08:40
11/18/19
11/18
08:40
11/18/19
08:40
Hot Stocks
Embraer says Air Peace signs firm order for three additional E195-E2 jets »

Embraer announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$130.73

5.62 (4.49%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.